Alzheimer's disease

Chinese pharma claims first Alzheimer’s drug approval since 2003
Pharmaforum
Mon, 11/4/19 - 10:34 am
China
Alzheimer's disease
Shanghai Green Valley Pharmaceuticals
Oligomannate
Small Alzheimer's hopeful biotech nabs $15M series B for metabolic drug approach
Fierce Biotech
Mon, 11/4/19 - 09:56 am
T3D Therapeutics
NIH
Alzheimer's disease
Research Roundup: What Are Microproteins and What Do They Do and More
BioSpace
Sat, 11/2/19 - 07:45 pm
microproteins
Alzheimer's disease
universal flu vaccine
R&D
Allergan pays $750m to avoid Alzheimer’s drug lawsuit
Pharmaforum
Mon, 10/28/19 - 11:31 pm
Allergan
Namenda
Alzheimer's disease
settlement
Biogen Alzheimer's Case Shows Danger of Trials Killing Good Drugs
Yahoo/Guru Focus
Mon, 10/28/19 - 11:09 pm
Biogen
Alzheimer's disease
aducanumab
clinical trials
drug development
More Details Emerge on Biogen’s Alzheimer’s Comeback
BioSpace
Mon, 10/28/19 - 10:31 am
Biogen
Alzheimer's disease
aducanumab
An Alzheimer’s patient on what was lost when Biogen shut down its trial, and what may be gained again
Stat
Fri, 10/25/19 - 10:40 am
Biogen
patients
Alzheimer's disease
aducanumab
clinical trials
Eli Lilly CEO Says Drugmaker Won’t Rehash Old Alzheimer’s Data
Bloomberg
Wed, 10/23/19 - 10:29 pm
Eli Lilly
Biogen
Alzheimer's disease
David Ricks
Biogen's Stock Could More Than Quadruple in Value in 5 Years
Motley Fool
Wed, 10/23/19 - 10:08 am
Biogen
biotech stocks
aducanumab
Alzheimer's disease
7 questions on Biogen's revival of a failed Alzheimer's drug
Biopharma Dive
Tue, 10/22/19 - 11:07 pm
Biogen
aducanumab
Alzheimer's disease
Alzheimer’s patients in Biogen trial, jolted by revival of drug, press for access once again
Stat
Tue, 10/22/19 - 10:56 pm
Biogen
Alzheimer's disease
FDA
aducanumab
Biogen resurrects aducanumab, arguing expanded data set supports FDA filing in Alzheimer's
Fierce Biotech
Tue, 10/22/19 - 11:05 am
Biogen
Alzheimer's disease
aducanumab
FDA
Charles River 'reaffirms' commitment to tough neuroscience beat
Fierce Biotech
Mon, 10/7/19 - 11:07 am
Charles River Laboratories
Neuroscience
Alzheimer's disease
Reeling from a hefty civil and criminal settlement, Avanir stumbles into PhIII Alzheimer's failure
Endpoints
Mon, 09/30/19 - 10:34 am
Avanir
Alzheimer's disease
clinical trials
Nuedexta
Research Might Lead to New Alzheimer’s Approaches
BioSpace
Thu, 09/19/19 - 08:08 pm
Alzheimer's disease
R&D
BioXcel to trial Apple Watch-drug combination to prevent Alzheimer’s agitation episodes
BioSpace
Thu, 09/19/19 - 12:33 pm
BioXcel
wearables
Apple Watch
Alzheimer's disease
BXCL501
Biogen, Eisai throw out remaining Alzheimer's BACE hope
Fierce Biotech
Fri, 09/13/19 - 10:45 am
Biogen
Eisai
Alzheimer's disease
BACE inhibitors
elenbecestat
aducanumab
Investors lost big as Alzheimer’s R&D went over the cliff in 2019. Will they ever come back?
Endpoints
Wed, 09/11/19 - 11:39 pm
Alzheimer's disease
R&D
Biogen
Neurotrope
Citing phase 2 figures, Axon looks for big pharma investment for Alzheimer’s vaccine
Pharmaforum
Mon, 09/9/19 - 08:10 pm
Alzheimer's disease
drug development
vaccines
Axon
New $17M Johns Hopkins research center to study psychedelic drugs in Alzheimer's, addiction and more
Fierce Biotech
Sat, 09/7/19 - 06:28 pm
psychedelic drugs
Johns Hopkins
drug development
Alzheimer's disease
addiction

Pages